Fariborz Kamal

2022

In 2022, Fariborz Kamal earned a total compensation of $2.4M as Chief Operating Officer & President at 4D Molecular Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$209,418
Option Awards$1,707,900
Salary$468,983
Total$2,386,301

Kamal received $1.7M in option awards, accounting for 72% of the total pay in 2022.

Kamal also received $209.4K in non-equity incentive plan and $469K in salary.

Rankings

In 2022, Fariborz Kamal's compensation ranked 1,518th out of 5,733 executives tracked by ExecPay. In other words, Kamal earned more than 73.5% of executives.

ClassificationRankingPercentile
All
1,518
out of 5,733
74th
Division
Manufacturing
768
out of 3,122
75th
Major group
Chemicals And Allied Products
299
out of 1,416
79th
Industry group
Drugs
277
out of 1,317
79th
Industry
Biological Products, Except Diagnostic Substances
70
out of 291
76th
Source: SEC filing on April 12, 2023.

Kamal's colleagues

We found two more compensation records of executives who worked with Fariborz Kamal at 4D Molecular Therapeutics in 2022.

2022

David Kirn

4D Molecular Therapeutics

Chief Executive Officer

2022

August Moretti

4D Molecular Therapeutics

Chief Financial Officer

News

In-depth

You may also like